Dilated Cardiomyopathy (DCM) is a serious heart condition characterized by the enlargement of the heart chambers, specifically the left ventricle. This disorder weakens the heart muscle, impairing its ability to pump blood efficiently. As a result, the heart becomes dilated and weakened, leading to a decrease in the overall pumping function. DCM can be caused by a variety of factors, including genetic predisposition, viral infections, certain medications, and exposure to toxins. The symptoms of DCM often include fatigue, shortness of breath, swelling in the legs, and an irregular heartbeat. Timely identification plays a pivotal role in effectively managing the condition and averting potential complications.. Treatment options may include medications, lifestyle changes, and in severe cases, heart transplant. Regular medical monitoring and adherence to a heart-healthy lifestyle are essential for individuals living with Dilated Cardiomyopathy.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India